Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19760952rdf:typepubmed:Citationlld:pubmed
pubmed-article:19760952lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:19760952lifeskim:mentionsumls-concept:C0031268lld:lifeskim
pubmed-article:19760952lifeskim:mentionsumls-concept:C0002210lld:lifeskim
pubmed-article:19760952lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:19760952lifeskim:mentionsumls-concept:C0046056lld:lifeskim
pubmed-article:19760952lifeskim:mentionsumls-concept:C1948041lld:lifeskim
pubmed-article:19760952lifeskim:mentionsumls-concept:C0032743lld:lifeskim
pubmed-article:19760952lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:19760952lifeskim:mentionsumls-concept:C1522609lld:lifeskim
pubmed-article:19760952lifeskim:mentionsumls-concept:C1554112lld:lifeskim
pubmed-article:19760952lifeskim:mentionsumls-concept:C0702240lld:lifeskim
pubmed-article:19760952lifeskim:mentionsumls-concept:C2697585lld:lifeskim
pubmed-article:19760952pubmed:issue93lld:pubmed
pubmed-article:19760952pubmed:dateCreated2009-9-17lld:pubmed
pubmed-article:19760952pubmed:abstractTextThe goal of this study was to assess the clinical usefulness of 18F-FDG PET/ CT for investigating unexplained serum AFP elevation following interventional therapy such as transarterial chemoembolization (TAE) or radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC).lld:pubmed
pubmed-article:19760952pubmed:languageenglld:pubmed
pubmed-article:19760952pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19760952pubmed:citationSubsetIMlld:pubmed
pubmed-article:19760952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19760952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19760952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19760952pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19760952pubmed:statusMEDLINElld:pubmed
pubmed-article:19760952pubmed:issn0172-6390lld:pubmed
pubmed-article:19760952pubmed:authorpubmed-author:PaikSeung...lld:pubmed
pubmed-article:19760952pubmed:authorpubmed-author:KohKwang...lld:pubmed
pubmed-article:19760952pubmed:authorpubmed-author:YooByung...lld:pubmed
pubmed-article:19760952pubmed:authorpubmed-author:ChoiMoon...lld:pubmed
pubmed-article:19760952pubmed:authorpubmed-author:LeeJoon...lld:pubmed
pubmed-article:19760952pubmed:authorpubmed-author:GwakGeum-Youn...lld:pubmed
pubmed-article:19760952pubmed:authorpubmed-author:HanA-ReumARlld:pubmed
pubmed-article:19760952pubmed:issnTypePrintlld:pubmed
pubmed-article:19760952pubmed:volume56lld:pubmed
pubmed-article:19760952pubmed:ownerNLMlld:pubmed
pubmed-article:19760952pubmed:authorsCompleteYlld:pubmed
pubmed-article:19760952pubmed:pagination1111-6lld:pubmed
pubmed-article:19760952pubmed:meshHeadingpubmed-meshheading:19760952...lld:pubmed
pubmed-article:19760952pubmed:meshHeadingpubmed-meshheading:19760952...lld:pubmed
pubmed-article:19760952pubmed:meshHeadingpubmed-meshheading:19760952...lld:pubmed
pubmed-article:19760952pubmed:meshHeadingpubmed-meshheading:19760952...lld:pubmed
pubmed-article:19760952pubmed:meshHeadingpubmed-meshheading:19760952...lld:pubmed
pubmed-article:19760952pubmed:meshHeadingpubmed-meshheading:19760952...lld:pubmed
pubmed-article:19760952pubmed:meshHeadingpubmed-meshheading:19760952...lld:pubmed
pubmed-article:19760952pubmed:meshHeadingpubmed-meshheading:19760952...lld:pubmed
pubmed-article:19760952pubmed:meshHeadingpubmed-meshheading:19760952...lld:pubmed
pubmed-article:19760952pubmed:meshHeadingpubmed-meshheading:19760952...lld:pubmed
pubmed-article:19760952pubmed:meshHeadingpubmed-meshheading:19760952...lld:pubmed
pubmed-article:19760952pubmed:meshHeadingpubmed-meshheading:19760952...lld:pubmed
pubmed-article:19760952pubmed:meshHeadingpubmed-meshheading:19760952...lld:pubmed
pubmed-article:19760952pubmed:meshHeadingpubmed-meshheading:19760952...lld:pubmed
pubmed-article:19760952pubmed:meshHeadingpubmed-meshheading:19760952...lld:pubmed
pubmed-article:19760952pubmed:meshHeadingpubmed-meshheading:19760952...lld:pubmed
pubmed-article:19760952pubmed:meshHeadingpubmed-meshheading:19760952...lld:pubmed
pubmed-article:19760952pubmed:meshHeadingpubmed-meshheading:19760952...lld:pubmed
pubmed-article:19760952pubmed:meshHeadingpubmed-meshheading:19760952...lld:pubmed
pubmed-article:19760952pubmed:meshHeadingpubmed-meshheading:19760952...lld:pubmed
pubmed-article:19760952pubmed:articleTitleThe clinical value of 18F-FDG PET/CT for investigating unexplained serum AFP elevation following interventional therapy for hepatocellular carcinom.lld:pubmed
pubmed-article:19760952pubmed:affiliationDepartment of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.lld:pubmed
pubmed-article:19760952pubmed:publicationTypeJournal Articlelld:pubmed